UNSPSC 42161915: Therapeutic apheresis machine waste divert lines

In this classification, this commodity indicates a product used as a waste divert line for therapeutic apheresis machine. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42161915 Therapeutic apheresis machine waste divert lines is a Commodity code, but the recent state and local opportunities tagged under it do not reflect apheresis-related procurement — instead, they show medical equipment and service solicitations across diagnostic imaging, surgical power instruments, ventilator maintenance, law enforcement equipment, and intraosseous infusion devices. The code shows a fundamental mismatch between its nominal scope and actual recent activity, suggesting either broad miscategorization by issuing bodies or that the code is not in active use for its intended purpose in state and local procurement.

The five recent opportunities span Florida (Valencia College, Marion County, Hillsborough County), California (San Mateo County Medical Center), and a multi-state cooperative vehicle through Sourcewell on behalf of Washington and other jurisdictions. Issuing bodies include two county public health systems (San Mateo Medical Center, Hillsborough County), a public college, a county emergency services division, and a regional cooperative purchasing entity. Representative solicitations include Valencia College's sole-source procurement for a Philips Affiniti 70 Ultrasound System ($96,093.00, posted October 19, 2026); San Mateo County's RFP for surgical power equipment on a five-year term (posted June 29, 2026, with questions due May 14, 2026, proposals due May 28, 2026); Hillsborough County's ITB for three-year ventilator maintenance and repair services on 40 Vyaire LTV 1200 units ($140,225.00 estimated value, bids due June 12, 2026); and Marion County's procurement notice for Vidacare EZ-IO intraosseous infusion systems (posted May 4, 2026, due May 11, 2026). Given the absence of apheresis-specific solicitations in the recent record, this code does not present a clear procurement avenue for vendors specializing in therapeutic plasma exchange or similar apheresis applications.